Wolverine Trading
NYMX

Wolverine Trading’s Nymox Pharmaceutical Corp NYMX Stock Holding History

Wolverine Trading’s Portfolio NYMX Stock Details NYMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-10,534
Closed -$27K – 5658
2020
Q3 		$27K Buy
10,534
+370
+4% +$1.08K ﹤0.01% 4365
2020
Q2 		$36K Sell
10,164
-412
-4% -$1.3K ﹤0.01% 4371
2020
Q1 		$23K Buy
+10,576
New +$29.7K ﹤0.01% 4409
2019
Q2 		– Sell
-10,547
Closed -$18.5K – 5319
2019
Q1 		$21K Sell
10,547
-16,061
-60% -$34.1K ﹤0.01% 4403
2018
Q4 		$38K Sell
26,608
-23,301
-47% -$42.7K ﹤0.01% 4213
2018
Q3 		$123K Buy
49,909
+7,702
+18% +$22.7K ﹤0.01% 4461
2018
Q2 		$179K Hold
42,207
– – ﹤0.01% 4453
2018
Q1 		$179K Sell
42,207
-19,483
-32% -$67.5K ﹤0.01% 4453
2017
Q4 		$204K Sell
61,690
-9,507
-13% -$34.7K ﹤0.01% 4135
2017
Q3 		$272K Buy
71,197
+41,529
+140% +$157K ﹤0.01% 3401
2017
Q2 		$136K Buy
+29,668
New +$122K ﹤0.01% 3795

Other funds holding NYMX

FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WB
Webster Bank Waterbury, Connecticut $1.15B AUM 23.08% 1-Year Est. Return
LSA
Leonteq Securities AG Zurich, Switzerland $2.91B AUM 56.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wolverine Trading's NYMX Position: Q4 2020 in Review

Wolverine Trading sold out of Nymox Pharmaceutical Corp (NYMX) in Q4 2020, closing a stake of 10,534 shares — an estimated $27K sold.

Wolverine Trading first reported a position in NYMX in Q2 2017 and held it in 11 quarters. The position peaked at $272K in Q3 2017. 58 funds tracked by Wall St. Rank hold NYMX as of Q4 2020.

  • Wolverine Trading reported no remaining Nymox Pharmaceutical Corp position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,534 Nymox Pharmaceutical Corp shares in Q4 2020, an estimated $27K.
  • Wolverine Trading first reported a position in Nymox Pharmaceutical Corp in Q2 2017 and held it in 11 quarters.
  • Wolverine Trading's Nymox Pharmaceutical Corp position peaked at $272K in Q3 2017.
  • 58 funds tracked by Wall St. Rank held Nymox Pharmaceutical Corp as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.